tiprankstipranks
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
US Market

Immix Biopharma, Inc. (IMMX) Stock Investors

96 Followers
Based on 729,232 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold IMMX
On average, investors allocate 0.00% of their portfolios to IMMX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 729,232 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IMMX

1.1%
Last 7
Days
4.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding IMMX, out of 729,232 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IMMX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$6.94
Based on the activity of 13,699 investors who made their portfolios public
The table shows changes in IMMX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IMMX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AMC Entertainment
5.44%
-1.01%
-6.73%
832.99M
Communication Services
Riot Platforms
4.96%
-0.82%
-0.97%
2.31B
Financial
Marathon Digital Holdings
5.51%
-0.69%
-3.33%
4.66B
Financial
GE Aerospace
5.50%
+1.58%
+6.13%
161.87B
Industrials
ChargePoint Holdings
3.89%
-1.27%
-7.40%
575.77M
Consumer Cyclical
Devon Energy
5.58%
-0.95%
-5.20%
32.91B
Energy
Enterprise Products Partners
5.83%
-0.25%
-2.60%
62.53B
Energy
UiPath
3.52%
-0.51%
-2.13%
10.67B
Technology
Coherus Biosciences
2.64%
-1.40%
-8.48%
234.94M
Healthcare
Novo Nordisk
5.50%
>-0.01%
-2.44%
554.15B
Healthcare
Based on the activity of 729,232 active portfolios
Open your Smart Portfolio

IMMX Investor Analysis

IMMX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
16.7%
of IMMX holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
IMMX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.3%
of IMMX holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
IMMX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.0%
of IMMX holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of IMMX stock investors
See who invests in IMMX according to age group and performance.

FAQ

How many retail Investors hold IMMX?
<0.1% of TipRanks' retail investors hold IMMX in their portfolios.
    What is IMMX Investor Sentiment?
    IMMX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of IMMX in the last 7 days?
      ▲ 1.1% of TipRanks' retail investors changed their holding of IMMX in the last 7 days.
        What percentage of retail investors changed their holding of IMMX in the last 30 days?
        ▼ 4.1% of TipRanks' retail investors changed their holding of IMMX in the last 30 days.
          What is the average age of retail investors who hold IMMX?
          The average age of IMMX Holders is between 35–55.
            What other stocks have IMMX investors also bought?
            IMMX Investors also bought AMC, RIOT, MARA, GE, CHPT, DVN, EPD, PATH, CHRS, NVO.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              AAgilent
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis